by Team Small News | Dec 2, 2025 | Divi's Laboratories
The Biosecure Act has created new opportunities for the Indian pharmaceutical industry. The Act, which aims to regulate the use of biotechnology and ensure the safe handling of biological materials, has opened doors for Indian pharma companies to engage in the...
by Team Small News | Nov 18, 2025 | Divi's Laboratories
Divi’s Laboratories, a leading pharmaceutical company, has successfully cleared a US FDA inspection with zero observations. This significant achievement demonstrates the company’s commitment to quality and compliance with regulatory standards. The...
by Team Small News | Nov 16, 2025 | Divi's Laboratories
The US Food and Drug Administration (USFDA) recently conducted an inspection of Unit 1 of Divi’s Laboratories Limited, a leading pharmaceutical company based in India. The inspection was a routine evaluation of the company’s compliance with current Good...